Pan T cells (human) | Human cell types | Human cells and organs | MACS Handbook | Resources | Miltenyi Biotec | USA
Frontiers | Chimeric Antigen Receptors for T-Cell Malignancies | Oncology
Frontiers | CD5, an Undercover Regulator of TCR Signaling | Immunology
T-cell therapies for T-cell lymphoma - Cytotherapy
Thymic and Extrathymic T Cell Development Pathways Follow Different Rules | The Journal of Immunology
CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation | PNAS
CD5 (protein) - Wikipedia
Effect of CD5 enhancer deletion on CD5 expression on splenic T cells.... | Download Scientific Diagram
CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels | Cellular & Molecular Immunology
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti- CD5 CAR T Cells | SpringerLink
CD5 on dendritic cells regulates CD4+ and CD8+ T cell activation and induction of immune responses | PLOS ONE
CD5 Helps Aspiring Regulatory T Cells Ward Off Unwelcome Cytokine Advances
JCI - CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice
CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens | PNAS
CD45-mediated control of TCR tuning in naïve and memory CD8+ T cells | Nature Communications
Effects of CD5 on different stages of T cell development. CD5... | Download Scientific Diagram
CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation | PNAS
CD5 expression by naive CD8+ T cells identifies stable populations with... | Download Scientific Diagram
CD5 (protein) - Wikipedia
T Cell Markers and B Cell Markers
IJMS | Free Full-Text | Emerging Role of T-cell Receptor Constant β Chain-1 (TRBC1) Expression in the Flow Cytometric Diagnosis of T-cell Malignancies | HTML
CD5 is downregulated during peripheral human CD8+ and CD4+ memory... | Download Scientific Diagram
CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity - Alotaibi - 2020 - European Journal of Immunology - Wiley Online Library
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy - Annals of Oncology
